BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 7, 2020
View Archived Issues
New aryl formyl piperidine derivatives reversibly inhibiting MAGL for the treatment of depression
Read More
ASO approach fixes myelin
Read More
FMF is Mediterranean's SCD
Read More
GB-1874, a novel inhibitor of Wnt signaling with activity in models of CRC
Read More
Amgen presents first orally available Mcl-1 inhibitor, AMG-397
Read More
OncoSec Medical divulges expression vectors encoding nucleic acid sequences for cancer
Read More
SIAT patents anti-H7N9 fully human monoclonal antibody 2G3 for H7N9 viral infection
Read More
Japanese researchers report new immunosuppressants
Read More
Sunshine Lake Pharma presents CD19-targeting antibodies
Read More
AdAlta moves AD-214 into the clinic
Read More
Researchers identify claudin 18.2-targeting antibodies
Read More
FDA lifts partial clinical hold on pivotal phase II study of camidanlumab tesirine
Read More
Clinical study of desidustat for the management of COVID-19 approved in Mexico
Read More
EXOSC4 gene is tied to breast cancer progression and poor survival
Read More
Suzhou Kintor Pharmaceuticals studies lead c-Myc/MAX protein-protein interaction inhibitor
Read More
Results from phase II RELIEF study of BLU-5937 in refractory chronic cough
Read More
Phase III ASCENT study of Trodelvy meets primary and key secondary endpoints
Read More
First participant enrolled in phase I study of ANAVEX 3-71
Read More
GI goblet cells prevent GvHD after stem cell transplant
Read More
CSL Behring initiates phase II study of CSL-312 for respiratory distress in patients with COVID-19
Read More
FDA places clinical hold on MELANI-01 study
Read More
Dimerix advances understanding of DMX-700 in COPD
Read More
ADGRG1 promotes TNBC progression and is a therapeutic druggable target
Read More
Otonomy reports treatment response in phase I/II trial of OTO-313 for tinnitus
Read More
Cabaletta opens enrollment in phase I study of DSG3-CAART in mucosal-dominant pemphigus vulgaris
Read More
European Commission approves Enerzair Breezhaler for uncontrolled asthma
Read More
Immune Regulation and DynPort partner to advance IRL-201104 for COVID-19-related ARDS
Read More